Gleevec and Tapazole drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Gleevec (imatinib mesylate) and Tapazole (methimazole). Common drug interactions include astrocytoma among females.

The phase IV clinical study analyzes what interactions people have when they take Gleevec and Tapazole. It is created by eHealthMe based on reports of 15 people who take the same drugs from the FDA, and is updated regularly.

What is Gleevec?

Gleevec has active ingredients of imatinib mesylate. It is often used in chronic myelogenous leukemia (cml). eHealthMe is studying from 35,415 Gleevec users. Check the latest studies of Gleevec.

What is Tapazole?

Tapazole has active ingredients of methimazole. It is often used in hyperthyroidism. eHealthMe is studying from 2,477 Tapazole users. Check the latest studies of Tapazole.

On Aug, 09, 2026

15 people who take Gleevec and Tapazole together, and have interactions are studied.

What are the common drug interactions of Gleevec and Tapazole, by gender? *:

female:

Astrocytoma (tumour of the brain that originate in a particular kind of glial-cells)
Basedow's disease (autoimmune disease where the thyroid is overactive, producing an excessive amount of thyroid hormones)
Mastocytosis (an excessive number of apparently normal mast cells in the skin and, occasionally, in other organs)
Metastasis (spreadable cancer to other organ from origin)
Mouth ulceration (mouth ulcers)
Nasal septum deviation (deviated nasal septum)
Oral disorder (mouth disease)
Oral pain
Osteoarthritis (a joint disease caused by cartilage loss in a joint)
Osteomyelitis (infection of bone)

male:

n/a

What are the common drug interactions of Gleevec and Tapazole, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

n/a

60+:

Astrocytoma (tumour of the brain that originate in a particular kind of glial-cells)
Basedow's disease (autoimmune disease where the thyroid is overactive, producing an excessive amount of thyroid hormones)
Mastocytosis (an excessive number of apparently normal mast cells in the skin and, occasionally, in other organs)
Metastasis (spreadable cancer to other organ from origin)
Mouth ulceration (mouth ulcers)
Nasal septum deviation (deviated nasal septum)
Oral disorder (mouth disease)
Oral pain
Osteoarthritis (a joint disease caused by cartilage loss in a joint)
Osteomyelitis (infection of bone)

What are the existing conditions these people have? *

Multiple Myeloma (cancer of the plasma cells): 14 people, 93.33%
Urticaria Pigmentosa (skin disease that produces patches of darker skin (lesions) and very bad itching): 13 people, 86.67%
Pancreatic Carcinoma (pancreatic cancer): 1 person, 6.67%
Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 1 person, 6.67%

* Approximation only. Some reports may have incomplete information.

Do you take Gleevec and Tapazole?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously